TENX 10-Q: SEC filing
Tenax Therapeutics
Filed with the SEC on · accession 0001193125-26-449796
TENX filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Tenax Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting 45,536,448 shares of common stock outstanding as of October 31, 2026.
Key details
How TENX stock reacted
Close before
$1.81
Nov 4, 2026
First close after
-9.94%
$1.63
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TENX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TENX?
Click hereFrequently asked questions
What did TENX file with the SEC on Nov 5, 2026?
TENX filed a 10-Q (SEC filing). Tenax Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting 45,536,448 shares of common stock outstanding as of October 31, 2026.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did TENX stock react to this filing?
TENX closed at $1.81 before the filing and $1.63 on Nov 5, 2026 (-9.94%).
Other TENX SEC filings
- 8-K · SEC filingOct 8, 2026
- 8-K · SEC filingSep 9, 2026
- 8-K · Fda approvalAug 10, 2026
- 8-K · SEC filingJul 31, 2026
- 10-Q · SEC filingJul 31, 2026
- 8-K · Fda approvalJul 2, 2026
- 8-K · Material agreementJun 30, 2026
- 8-K · Executive departureJun 29, 2026
- 8-K · Board changeJun 4, 2026
- 10-Q · SEC filingMay 12, 2026
Get alerts when TENX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days